Riskpilot← Back to searchSign inGet full accessHCG UTVIKLING AS
ASActiveOrg 924405082Kartverksveien 2, 3511 HønefossRental and operating of own or leased real estate · NACE 6820Est. 20200 employees
Revenue 2024
NOK 192K
0% vs 2023
EBITDA margin
-17.2%
-125% vs 2023
Equity ratio
-37.2%
Financial strength
Net profit 2024
NOK -248K
-198% vs 2023
| Revenue | NOK 192K | +0% |
| EBITDA | NOK -33K | -125% |
| Net profit | NOK -248K | -198% |
| Total assets | NOK 3,2M | +4% |
| Equity | NOK -1,2M | -27% |
| Employees | 0 | — |
Legal name
HCG UTVIKLING AS
Org number
924405082
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
29. januar 2020
Share capital
NOK 45 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Drift, utvikling og forvaltning av eiendom, samt alt som hører naturlig til dette.
Address
Kartverksveien 2, 3511 Hønefoss
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 206 | 200 | 192 | 192 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −804 | 134 | 140 | 134 | −33 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −804 | 134 | 140 | 134 | −33 |
| Net financials | −86 | −94 | −179 | −217 | −215 |
| Profit before tax | −890 | 40 | −39 | −83 | −248 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −890 | 40 | −39 | −83 | −248 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 071 | 3 089 | 3 074 | 3 048 | 3 176 |
| Equity | −851 | −811 | −849 | −933 | −1 180 |
| Long-term debt | 2 560 | 3 878 | 3 898 | 3 950 | 4 342 |
| Short-term debt | 1 361 | 21 | 25 | 30 | 14 |
| Total debt | 3 921 | 3 899 | 3 923 | 3 980 | 4 357 |
EBITDA margin
-17.2%
This company
15.8%
Market median
-209% vs market
20202024
Equity ratio
-37.2%
This company
38.2%
Market median
-197% vs market
20202024
Return on equity
-24796100.0%
This company
18.4%
Market median
-134761513% vs market
20202024
Net profit margin
-129.1%
This company
8.1%
Market median
-1694% vs market
20202024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20202024
Debt / equity
3.69×
This company
0.62×
Market median
-495% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MB Deputy Member | Deputy Member | 2020 |
CB Deputy Member | Deputy Member | 2020 |
EH Deputy Member | Deputy Member | 2020 |
EH Deputy Member | Deputy Member | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.4% | 33.4% | 2022 | |
| Company | 33.3% | 33.3% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Opsal Holding As
HCG UTVIKLING AS Board members of HCG UTVIKLING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mikkel Berg Hauge | Deputy Member | 0 companies |
| Casper Berg Hauge | Deputy Member | 0 companies |
| Emil Holm Opsal | Deputy Member | 0 companies |
| Eirik Holm Opsal | Deputy Member | 0 companies |
| Gunnar Opsal | Board of Directors | 0 companies |
| Henning Sjøvaag | Board of Directors | 0 companies |
| Cato Strandås Hauge | Chairman | 0 companies |